Genotypic Changes in Human Immunodeficiency Virus Type 1 Associated with Loss of Suppression of Plasma Viral RNA Levels in Subjects Treated with Ritonavir (Norvir) Monotherapy
Ten subjects received 600 to 1,200 mg of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor ritonavir per day. Following 2 weeks of therapy, plasma HIV RNA levels decreased by a mean of 1.57 (range, 0.89 to 1.96) log units. With continued therapy, HIV RNA levels began to rise in eigh...
Na minha lista:
| Udgivet i: | J Virol |
|---|---|
| Principais autores: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1998
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC110088/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9573287/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.72.6.5154-5164.1998 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
